Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update

The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn’s disease

(2012) Jarosław Kierkus et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Risk of Infection and Prevention in Pediatric Patients With IBD

(2012) Gigi Veereman-Wauters et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

(2011) C. Steenholdt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment

(2011) Ingrid Arijs et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Regulatory macrophages: Setting the Threshold for Therapy

(2011) Bryan D. Fleming et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF  treatment

(2011) C. Veltkamp et al.   GUT

Genetics and pathogenesis of inflammatory bowel disease

(2011) Bernard Khor et al.   NATURE

Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn's Disease: A Predictor of Lymphoma Risk?

(2011) Jens Kelsen et al.   PLoS One

The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

(2010) Keith Brew et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease

(2010) Gregory Bouchaud et al.   GASTROENTEROLOGY

Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study

(2010) Livia Biancone et al.   INFLAMMATORY BOWEL DISEASES

Severe neutropenia following infliximab treatment in a child with ulcerative colitis

(2010) Mary Sherlock et al.   INFLAMMATORY BOWEL DISEASES

Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

(2010) Marisa Iborra et al.   Journal of Crohns & Colitis

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

(2010) Andre Franke et al.   NATURE GENETICS

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

(2009) S. SCHNEEWEISS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mitogen activated protein kinases: a role in inflammatory bowel disease?

(2009) O. J. Broom et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Modulation of inflammatory response via α2-adrenoceptor blockade in acute murine colitis

(2009) A. Bai et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Therapeutic Options to Modulate Barrier Defects in Inflammatory Bowel Disease

(2009) Nina A. Hering et al.   DIGESTIVE DISEASES

Biological Therapies for Inflammatory Bowel Diseases

(2009) Paul Rutgeerts et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Genome wide association (GWA) predictors of anti-TNFα therapeutic responsiveness in pediatric inflammatory bowel disease

(2009) Marla C. Dubinsky et al.   INFLAMMATORY BOWEL DISEASES

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology

Infliximab therapy decreases the levels of TNF-α and IFN-γ mRNA in colonic mucosa of ulcerative colitis

(2009) Trine Olsen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Emerging treatments for complex perianal fistula in Crohn’s disease

(2009) Carlos Taxonera et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Review: Predicting response to anti-TNF agents for the treatment of Crohn's disease

(2009) Corey A. Siegel et al.   Therapeutic Advances in Gastroenterology

The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation

(2008) Yinghua Xu et al.   CELL RESEARCH

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

(2008) S. Danese   DIGESTIVE AND LIVER DISEASE

Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?

(2008) William J. Sandborn   GASTROENTEROLOGY

VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis

(2008) Franco Scaldaferri et al.   GASTROENTEROLOGY

Dietary Histidine Ameliorates Murine Colitis by Inhibition of Proinflammatory Cytokine Production From Macrophages

(2008) Ayatoshi Andou et al.   GASTROENTEROLOGY

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

(2008) T Kobayashi et al.   GUT

Anti tumour necrosis-α therapy increases the number of FOXP3+regulatory T cells in children affected by Crohn’s disease

(2008) Ida Ricciardelli et al.   IMMUNOLOGY

Modulation of the Th1/Th2 Balance by Infliximab Improves Hyperthyroidism Associated with a Flare-up of Ulcerative Colitis

(2008) Kayoko Matsumura et al.   INFLAMMATORY BOWEL DISEASES

Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis

(2008) Nobuhiko Kamada et al.   JOURNAL OF CLINICAL INVESTIGATION

NF-κB in inflammatory bowel disease

(2008) I. Atreya et al.   JOURNAL OF INTERNAL MEDICINE

Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohnʼs colitis

(2007) Arun Swaminath et al.   INFLAMMATORY BOWEL DISEASES